Irrational Prescribing in South Asia: A Case of Fluoroquinolone-associated Phototoxicity

Journal of Travel Medicine

Volumn 10, Issue 5, 2003, Pages 290-292

  Cave, William ^a,c   Pandey, Prativa ^a   Chatterjee, Santanu ^b  

^a CIWEC Travel Medicine Centre Nepal   (Nepal)

^b Wellesley Medicentre   (India)

^c Waypoint Travel Clinic   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CETIRIZINE; DIMETINDENE; MEFLOQUINE; PREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; SPARFLOXACIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HERPES ZOSTER; HUMAN; PHOTOTOXICITY; PRESCRIPTION; SOUTH ASIA; TREATMENT OUTCOME;

EID: 0142136825     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2003.2726     Document Type: Article

References (11)

1. Phakde AR. The quality of prescribing in an Indian district. Nat Med J India 1996; 9(2):60-65.
2. Hazra A, Tripathi SK, Alam MS. Prescribing and dispensing activities at the health facilities of a non-governmental organization. Nat Med J India 2000;13(4):177-182.
3. Dineshkumar B, Raghuram TC, Radhaiah G, Krishnaswamy K. Profile of drug use in rural India. Pharmacoeconomics 1995;7(4):332-346.
4. Kuruvilla A, George K, Rajaratnam A, John KR. Prescription patterns and cost analysis of drugs in a base hospital in South India. Nat Med J India 1994;7(4):167-168.
5. Das N, Khan AN, Badini ZA, et al. Prescribing practices of consultants at Karachi, Pakistan. J Pak Med Assoc 2001; 51(2):74-77.
6. Kshirsagar MJ, Langade D, Patil S, Pakti PS. Prescribing patterns among medical practitioners in Pune, India. Bull World Health Organ 1998; 76(3):271-275.
7. Rehan HS, Vasudev K, Tripathi CD. Adverse reaction monitoring: knowledge, attitude and practices of medical students and prescribers. Nat Med J India 2002; 15:24-26.
8. Singla R, Gupta R, Arora VK. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multi-resistant pulmonary tuberculosis patients: preliminary results. Int J Tuberc Lung Dis 2001; 5(6):559-563.
9. Stahlmann R, Lode H. Toxicity of quinolones. Drugs 1999; 58(Suppl 2):37-42.
10. Rubenstein E. History of quinolones and their side effects. Chemotherapy 2001; 47(Suppl 3):3-8.
11. Ball P. Safety of the new fluoroquinolones compared with ciprofloxacin. J Chemother 2000; 12(Suppl 1):8-11.